Resultados de la búsqueda 371-380 of 1762 for Anabolic

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...

3. Oncología (médica) - Ensayos clínicos

   There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...

4. Oncología (médica) - Ensayos clínicos

   There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...

5. Oncología radioterápica - Ensayos clínicos

   Rochester, Minn., Scottsdale/Phoenix, Ariz. The standard treatment for locally advanced rectal cancer involves chemotherapy and radiation, known as 5FUCMT, (the ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Rochester, Minn. The purposes of this study are to analyze the ovarian function of female premenopausal melanoma survivors who have undergone immunotherapy, and ...

7. Oncología (médica) - Ensayos clínicos

   Rochester, Minn. 99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates ...

8. Oncología (médica) - Ensayos clínicos

   Rochester, Minn. 99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to investigate the effectiveness and safety of REC-2282 in patients with progressive NF2 mutated meningiomas who have either NF2 ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...